Back
Calamos Strategic Total Return Fund Vs. ResMed Industry Stock Comparison
Buy
73
CSQ
Calamos Strategic Total Return Fund
Last Price:
17.27
Seasonality Move:
0.49%
Sell
37
RMD
ResMed
Last Price:
238.89
Seasonality Move:
9.63%
Buy
73
Calamos Strategic Total Return Fund (CSQ)
is a Buy
Is Calamos Strategic Total Return Fund a Buy, Sell or Hold?
- The current Calamos Strategic Total Return Fund [CSQ] share price is $17.27. The Score for CSQ is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- CSQ is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
ResMed (RMD)
is a Sell
Is ResMed a Buy, Sell or Hold?
- The current ResMed [RMD] share price is $239.00. The Score for RMD is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- RMD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CSQ Stock Price Chart
What is Calamos Strategic Total Return Fund's stock price today?
-
The Calamos Strategic Total Return Fund share price today is $17.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CSQ is experiencing slight buying pressure.
RMD Stock Price Chart
CSQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 61.48 | Buy |
| Chaikin Money Flow: | 58929 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.64 - 17.18) | Buy |
| Bollinger Bands (100): | (16.3 - 17.1) | Buy |
RMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.17 | Buy |
| Relative Strength Index (14 RSI): | 48.53 | Sell |
| Chaikin Money Flow: | -1050033 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (237.55 - 250.79) | Sell |
| Bollinger Bands (100): | (200 - 236.14) | Buy |
CSQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.19 | Buy |
| 20-day SMA: | 16.9 | Buy |
| 50-day SMA: | 16.75 | Buy |
| 200-day SMA: | 16.14 | Buy |
| 8-day EMA: | 17.17 | Buy |
| 20-day EMA: | 17 | Buy |
| 50-day EMA: | 16.84 | Buy |
| 200-day EMA: | 16.15 | Buy |
RMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 242.7 | Sell |
| 20-day SMA: | 246.18 | Sell |
| 50-day SMA: | 229.88 | Buy |
| 200-day SMA: | 201.27 | Buy |
| 8-day EMA: | 243.22 | Sell |
| 20-day EMA: | 242.45 | Sell |
| 50-day EMA: | 232.43 | Buy |
| 200-day EMA: | 208.09 | Buy |
Calamos Strategic Total Return Fund Earnings Growth & CSQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ResMed Earnings Growth & RMD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.05 per share, an increase this year of $1.19 per share, and an increase next year of $1.40 per share.
Calamos Strategic Total Return Fund Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ResMed Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||